LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 50 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,601,000 | +8.3% | 1,647,000 | +11.7% | 0.00% | 0.0% |
| Q3 2021 | $1,478,000 | -21.8% | 1,475,000 | -22.8% | 0.00% | 0.0% |
| Q2 2021 | $1,889,000 | -15.2% | 1,911,000 | -11.2% | 0.00% | 0.0% |
| Q1 2021 | $2,228,000 | +41.8% | 2,153,000 | +29.0% | 0.00% | 0.0% |
| Q4 2020 | $1,571,000 | +9.2% | 1,669,000 | +4.7% | 0.00% | 0.0% |
| Q3 2020 | $1,438,000 | +167.8% | 1,594,000 | +145.2% | 0.00% | – |
| Q1 2020 | $537,000 | -72.9% | 650,000 | -71.7% | 0.00% | -100.0% |
| Q4 2019 | $1,980,000 | -14.3% | 2,295,000 | -17.3% | 0.00% | -50.0% |
| Q3 2019 | $2,311,000 | -74.6% | 2,774,000 | -73.7% | 0.00% | -60.0% |
| Q2 2019 | $9,102,000 | – | 10,545,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 59,956,000 | $49,653,000 | 4.88% |
| SYMPHONY ASSET MANAGEMENT LLC | 18,000,000 | $14,906,000 | 4.68% |
| CANYON CAPITAL ADVISORS LLC | 60,000,000 | $49,708,000 | 1.76% |
| Venator Capital Management Ltd. | 1,500,000 | $1,250,000 | 1.28% |
| Context Capital Management, LLC | 2,350,000 | $1,968,000 | 1.12% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $18,577,000 | 0.50% |
| OAKTREE CAPITAL MANAGEMENT LP | 18,865,000 | $15,622,000 | 0.44% |
| AQR Arbitrage LLC | 13,431,000 | $11,123,000 | 0.37% |
| SSI INVESTMENT MANAGEMENT LLC | 4,000,000 | $3,303,000 | 0.29% |
| CAMDEN ASSET MANAGEMENT L P /CA | 11,600,000 | $9,577,000 | 0.28% |